Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Primary Prevention
DOI:
10.2337/dc18-1970
Publication Date:
2019-03-15T19:11:46Z
AUTHORS (287)
ABSTRACT
We examined the effects of metformin on diabetes prevention and subgroups that benefited most over 15 years in Diabetes Prevention Program (DPP) its follow-up, Outcomes Study (DPPOS).During DPP (1996-2001), adults at high risk developing were randomly assigned to masked placebo (n = 1,082) or 850 mg twice daily 1,073). Participants originally continued receive metformin, unmasked, DPPOS (2002-present). Ascertainment development was based fasting 2-h glucose levels after an oral tolerance test HbA1c. Reduction incidence with compared by hazard ratio (HR) rate differences (RDs).During postrandomization reduced (by HR) 17% 36% HbA1c levels, respectively. Metformin's effect glucose-defined greater for women a history prior gestational mellitus (GDM) (HR 0.59, RD -4.57 cases/100 person-years) parous without GDM 0.94, -0.38 person-years [interaction P 0.03 HR, 0.01 RD]). Metformin also had effects, HR RD, higher baseline levels. With HbA1c, more effective subjects -1.03 <6.0% (42 mmol/mol) -3.88 6.0-6.4% (P 0.0001).Metformin reduces years. The subsets benefitted include GDM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (96)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....